Logo image of ZIL2.DE

ELRINGKLINGER AG (ZIL2.DE) Stock Fundamental Analysis

Europe - FRA:ZIL2 - DE0007856023 - Common Stock

4.085 EUR
0 (0%)
Last: 10/30/2025, 11:40:39 AM
Fundamental Rating

3

Taking everything into account, ZIL2 scores 3 out of 10 in our fundamental rating. ZIL2 was compared to 32 industry peers in the Automobile Components industry. ZIL2 may be in some trouble as it scores bad on both profitability and health. ZIL2 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ZIL2 has reported negative net income.
ZIL2 had a positive operating cash flow in the past year.
In multiple years ZIL2 reported negative net income over the last 5 years.
ZIL2 had a positive operating cash flow in each of the past 5 years.
ZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of ZIL2 (-9.30%) is worse than 90.63% of its industry peers.
ZIL2 has a worse Return On Equity (-27.39%) than 81.25% of its industry peers.
Industry RankSector Rank
ROA -9.3%
ROE -27.39%
ROIC N/A
ROA(3y)-3.41%
ROA(5y)-1.93%
ROE(3y)-9.27%
ROE(5y)-5.38%
ROIC(3y)N/A
ROIC(5y)N/A
ZIL2.DE Yearly ROA, ROE, ROICZIL2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

In the last couple of years the Operating Margin of ZIL2 has declined.
ZIL2 has a Gross Margin of 21.95%. This is in the lower half of the industry: ZIL2 underperforms 62.50% of its industry peers.
ZIL2's Gross Margin has improved in the last couple of years.
ZIL2 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.95%
OM growth 3Y-19.39%
OM growth 5Y-2.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.81%
GM growth 5Y3.28%
ZIL2.DE Yearly Profit, Operating, Gross MarginsZIL2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

ZIL2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZIL2 remains at a similar level compared to 1 year ago.
The number of shares outstanding for ZIL2 remains at a similar level compared to 5 years ago.
The debt/assets ratio for ZIL2 has been reduced compared to a year ago.
ZIL2.DE Yearly Shares OutstandingZIL2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ZIL2.DE Yearly Total Debt VS Total AssetsZIL2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

ZIL2 has an Altman-Z score of 1.33. This is a bad value and indicates that ZIL2 is not financially healthy and even has some risk of bankruptcy.
ZIL2 has a Altman-Z score of 1.33. This is in the lower half of the industry: ZIL2 underperforms 65.63% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that ZIL2 is somewhat dependend on debt financing.
ZIL2 has a better Debt to Equity ratio (0.56) than 65.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Altman-Z 1.33
ROIC/WACCN/A
WACC5.36%
ZIL2.DE Yearly LT Debt VS Equity VS FCFZIL2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.37 indicates that ZIL2 should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.37, ZIL2 is doing good in the industry, outperforming 65.63% of the companies in the same industry.
ZIL2 has a Quick Ratio of 1.37. This is a bad value and indicates that ZIL2 is not financially healthy enough and could expect problems in meeting its short term obligations.
ZIL2 has a worse Quick ratio (0.65) than 78.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.65
ZIL2.DE Yearly Current Assets VS Current LiabilitesZIL2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

ZIL2 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -412.06%.
ZIL2 shows a decrease in Revenue. In the last year, the revenue decreased by -4.26%.
The Revenue has been growing slightly by 0.87% on average over the past years.
EPS 1Y (TTM)-412.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-194.13%
Revenue 1Y (TTM)-4.26%
Revenue growth 3Y3.54%
Revenue growth 5Y0.87%
Sales Q2Q%-8.24%

3.2 Future

The Earnings Per Share is expected to grow by 74.86% on average over the next years. This is a very strong growth
ZIL2 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.67% yearly.
EPS Next Y187.1%
EPS Next 2Y103.2%
EPS Next 3Y74.86%
EPS Next 5YN/A
Revenue Next Year-9.67%
Revenue Next 2Y-3.16%
Revenue Next 3Y-0.07%
Revenue Next 5Y1.67%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZIL2.DE Yearly Revenue VS EstimatesZIL2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
ZIL2.DE Yearly EPS VS EstimatesZIL2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZIL2. In the last year negative earnings were reported.
ZIL2 is valuated cheaply with a Price/Forward Earnings ratio of 6.07.
75.00% of the companies in the same industry are more expensive than ZIL2, based on the Price/Forward Earnings ratio.
ZIL2 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.07
ZIL2.DE Price Earnings VS Forward Price EarningsZIL2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZIL2 is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.04
ZIL2.DE Per share dataZIL2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ZIL2's earnings are expected to grow with 74.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.2%
EPS Next 3Y74.86%

3

5. Dividend

5.1 Amount

ZIL2 has a Yearly Dividend Yield of 3.67%.
ZIL2's Dividend Yield is comparable with the industry average which is at 4.76.
Compared to an average S&P500 Dividend Yield of 2.31, ZIL2 pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

The dividend of ZIL2 decreases each year by -23.34%.
Dividend Growth(5Y)-23.34%
Div Incr Years0
Div Non Decr Years3
ZIL2.DE Yearly Dividends per shareZIL2.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1

5.3 Sustainability

DPN/A
EPS Next 2Y103.2%
EPS Next 3Y74.86%
ZIL2.DE Yearly Income VS Free CF VS DividendZIL2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

ELRINGKLINGER AG

FRA:ZIL2 (10/30/2025, 11:40:39 AM)

4.085

0 (0%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-06 2025-08-06
Earnings (Next)11-12 2025-11-12
Inst Owners4.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap258.83M
Revenue(TTM)1.72B
Net Income(TTM)-166757000
Analysts76.36
Price Target5.34 (30.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend0.15
Dividend Growth(5Y)-23.34%
DPN/A
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-59.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.07
P/S 0.15
P/FCF N/A
P/OCF 2.39
P/B 0.43
P/tB 0.53
EV/EBITDA 5.04
EPS(TTM)-2.63
EYN/A
EPS(NY)0.67
Fwd EY16.48%
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)1.71
OCFY41.88%
SpS27.21
BVpS9.61
TBVpS7.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.3%
ROE -27.39%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.95%
FCFM N/A
ROA(3y)-3.41%
ROA(5y)-1.93%
ROE(3y)-9.27%
ROE(5y)-5.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.36%
ROCE(5y)5%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-19.39%
OM growth 5Y-2.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.81%
GM growth 5Y3.28%
F-Score3
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF N/A
Debt/EBITDA 2.68
Cap/Depr 52.9%
Cap/Sales 9.09%
Interest Coverage N/A
Cash Conversion 85.68%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.65
Altman-Z 1.33
F-Score3
WACC5.36%
ROIC/WACCN/A
Cap/Depr(3y)55.78%
Cap/Depr(5y)58.16%
Cap/Sales(3y)5.89%
Cap/Sales(5y)5.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-412.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-194.13%
EPS Next Y187.1%
EPS Next 2Y103.2%
EPS Next 3Y74.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.26%
Revenue growth 3Y3.54%
Revenue growth 5Y0.87%
Sales Q2Q%-8.24%
Revenue Next Year-9.67%
Revenue Next 2Y-3.16%
Revenue Next 3Y-0.07%
Revenue Next 5Y1.67%
EBIT growth 1Y-296.76%
EBIT growth 3Y-16.53%
EBIT growth 5Y-1.19%
EBIT Next Year2275.32%
EBIT Next 3Y218.16%
EBIT Next 5YN/A
FCF growth 1Y-569.42%
FCF growth 3Y-17.62%
FCF growth 5Y-25.51%
OCF growth 1Y3.55%
OCF growth 3Y2.48%
OCF growth 5Y-9.55%

ELRINGKLINGER AG / ZIL2.DE FAQ

Can you provide the ChartMill fundamental rating for ELRINGKLINGER AG?

ChartMill assigns a fundamental rating of 3 / 10 to ZIL2.DE.


What is the valuation status of ELRINGKLINGER AG (ZIL2.DE) stock?

ChartMill assigns a valuation rating of 4 / 10 to ELRINGKLINGER AG (ZIL2.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ELRINGKLINGER AG?

ELRINGKLINGER AG (ZIL2.DE) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for ZIL2 stock?

The Earnings per Share (EPS) of ELRINGKLINGER AG (ZIL2.DE) is expected to grow by 187.1% in the next year.